How clinically useful is comprehensive genomic profiling for patients with non-small cell lung cancer? A systematic review-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

How clinically useful is comprehensive genomic profiling for patients with non-small cell lung cancer? A systematic review

Published:2021-10 Issue: Volume:166 Page:103459
ISSN:1040-8428
Container-title:Critical Reviews in Oncology/Hematology
language:en
Short-container-title:Critical Reviews in Oncology/Hematology

Author:

Torres Gabriel Fernando^ORCID,Bonilla Carlos Eduardo^ORCID,Buitrago Giancarlo^ORCID,Arrieta Oscar,Malapelle Umberto,Rolfo Christian,Cardona Andrés F.

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference62 articles.

1. Comprehensive genomic profiling identifies a subset of crizotinib-responsive ALK-Rearranged non-small cell lung cancer not detected by fluorescence in situ hybridization;Ali;Oncologist,2016

2. The nuts and bolts of PROSPERO: an international prospective register of systematic reviews;Booth;Syst. Rev.,2012

3. Nivolumab versus docetaxel in advanced nonsquamous non-small-cell lung cancer;Borghaei;N. Engl. J. Med.,2015

4. Nivolumab versus docetaxel in advanced squamous-cell non-small-cell lung cancer;Brahmer;N. Engl. J. Med.,2015

5. Updated efficacy and safety data and impact of the EML4-ALK fusion variant on the efficacy of Alectinib in untreated ALK-positive advanced non–small cell lung cancer in the global phase III ALEX study;Camidge;J. Thorac. Oncol.,2019

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Personalized medicine: Clinical oncology on molecular view of treatment;World Journal of Clinical Oncology;2024-08-24

2. Cost-Effectiveness of Comprehensive Genomic Profiling in Patients With Non–Small Cell Lung Cancer for the Colombian Health System;Value in Health Regional Issues;2024-01

3. Survival Outcomes of Metastatic Non-small Cell Lung Cancer Patients With Limited Access to Immunotherapy and Targeted Therapy in a Cancer Center of a Low- and Middle-Income Country;Cancer Control;2023-04

4. Next generation diagnostic algorithm in non-small cell lung cancer predictive molecular pathology: The KWAY Italian multicenter cost evaluation study;Critical Reviews in Oncology/Hematology;2022-01

5. Anticipating EGFR Targeting in Early Stages of Lung Cancer: Leave No Stone Unturned;Cells;2021-10-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3